-
The Upstream and Downstream products of 3-(MethylaMino)pyridazine-4-carbonitrile
Time of Update: 2023-05-17
Keywords: MMPZ-4-CN, organic compound, nitrogen-containing heterocyclic compound, upstream products, downstream products, N-methylpyrrole-2-carboxamide, N-methylpyrrole-3-carboxamide, pharmaceuticals, agrochemicals, pyridazine derivatives, indoles, imidazoles, polymers, synthetic polymers, dyes, pigments, herbic 3-(MethylaMino)pyridazine-4-carbonitrile, also known as MMPZ-4-CN, is an organic compound that is used as a raw material in the chemical industry.
-
The Upstream and Downstream products of 5-CHLOROPYRIDAZIN-3-OL
Time of Update: 2023-05-09
5-chloropyridazine-3-ol is used in the production of these chemicals due to its unique properties, such as its ability to control pest populations and prevent the growth of weeds and fungi.
-
2022 China (Weifang) Animal Products Industry Development Summit Forum was held in Weifang
Time of Update: 2022-09-06
News from this website On August 28, the 2022 China (Weifang) Animal Products Prepared Vegetable Industry Development Summit Forum was held at Fuhua Hotel, Weifang City, Shandong Province .
-
The four departments issued a document saying "no" to the plastic book cover, and it is more environmentally friendly to do it yourself
Time of Update: 2022-08-21
Although the school season has passed, there are still book covers in the sales of stationery, and most of them are plastic book covers The reporter visited several stationery stores in the urban area.
-
The difference between madder, dragon's blood and dragon's blood and dragon's blood
Time of Update: 2022-06-17
Table 18-6 Comparison of traits identification characteristics of madder chaotic varieties Dragon's BloodThe nationally used dragon's blood is processed from the resin exuded from the fruit of the palm family Daemonorops draco Bl.
-
The rapid expansion of domestic pharmaceutical companies in the first half of the year drove the growth in demand for high-clean application materials
Time of Update: 2022-02-22
Original title: The rapid expansion of domestic pharmaceutical companies in the first half of 2021 will drive the growth of market demand for high-clean application materials
-
In 2021, 83 new drugs will be approved, 19 will be included in medical insurance, and Roche and BeiGene will be the first in the number of approvals
Time of Update: 2022-01-21
On June 23, Fosun Kite's akirenxe injection was approved for marketing for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after receiving second-line or above systemic therapy .
-
Aimike, which only sells hyaluronic acid, has doubled its profit and income in the first quarter
Time of Update: 2021-07-07
According to its 2021 annual report, this type of product achieved operating income of 450 million yuan, an increase of 82.
According to its annual report, gel injection products will reach 252 million yuan in 2020, accounting for 35.
-
"Major new drug creation" special to encourage major varieties of research and development and industrialization
Time of Update: 2020-06-03
Business Agency, March 14 Ministry of Health, the Ministry of Health after the 13th issued the "major new drug creation" science and technology major special "12th Five-Year Plan" implementation
